Condition
Diabetic Foot Osteomyelitis
Total Trials
7
Recruiting
1
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
14.3%
1 terminated out of 7 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Unknown3
Active Not Recruiting1
Completed1
Terminated1
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT06010433Recruiting
CERAMENT G Device Registry
NCT05177107Phase 2Terminated
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
NCT05539963Phase 2Active Not RecruitingPrimary
A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis
NCT06808568Unknown
Expanded Access Program (EAP) STIMULAN VG
NCT04240964CompletedPrimary
Studying on the Difference Between Two Kinds of Osteomyelitis
NCT04041739UnknownPrimary
Fungal Infection in Patients With Diabetic Foot Osteomyelitis
NCT02927678UnknownPrimary
White Blood Cell SPECT/CT and Diabetic Foot Osteomyelitis
Showing all 7 trials